On 2024-11-7 Global Info Research released【Global Nanoparticle Drug Delivery Systems Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030】. This report includes an overview of the development of the Nanoparticle Drug Delivery Systems industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nanoparticle Drug Delivery Systems.
Sample Report Request Nanoparticle Drug Delivery Systems
https://www.globalinforesearch.com/reports/2351206/nanoparticle-drug-delivery-systems
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery. In this report, we only study liposomal/lipid nanoparticle drug delivery system. LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines). In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
Market segment by Type：Liposomes Drugs、Lipid Nanoparticle Drugs
Market segment by Application：Hospital、Retail Pharmacy、Other
Major players covered： Johnson & Johnson、Sun Pharmaceutical、CSPC、Kinyond、Teva、Fudan-Zhangjiang、Zydus Cadila、TTY Biopharma、Pacira、Luye Pharma、Leadiant Biosciences、Ipsen、Sayre Therapeutics、Jazz、Alnylam、Bausch Health、Acrotech Biopharma、Takeda、Chiesi Farmaceutici、Gilead Sciences、Pfizer
Table of Contents
1 Supply Summary
1.1 Nanoparticle Drug Delivery Systems Introduction
1.2 World Nanoparticle Drug Delivery Systems Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Nanoparticle Drug Delivery Systems Total Market by Region (by Headquarter Location)
1.3.1 World Nanoparticle Drug Delivery Systems Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.3.3 China Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.3.4 Europe Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.3.5 Japan Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.3.6 South Korea Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.3.7 ASEAN Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.3.8 India Based Company Nanoparticle Drug Delivery Systems Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nanoparticle Drug Delivery Systems Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 Demand Summary
2.1 World Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.2 World Nanoparticle Drug Delivery Systems Consumption Value by Region
2.2.1 World Nanoparticle Drug Delivery Systems Consumption Value by Region (2019-2024)
2.2.2 World Nanoparticle Drug Delivery Systems Consumption Value Forecast by Region (2025-2030)
2.3 United States Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.4 China Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.5 Europe Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.6 Japan Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.7 South Korea Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.8 ASEAN Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
2.9 India Nanoparticle Drug Delivery Systems Consumption Value (2019-2030)
3 World Nanoparticle Drug Delivery Systems Companies Competitive Analysis
3.1 World Nanoparticle Drug Delivery Systems Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nanoparticle Drug Delivery Systems Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nanoparticle Drug Delivery Systems in 2023
3.2.3 Global Concentration Ratios (CR8) for Nanoparticle Drug Delivery Systems in 2023
3.3 Nanoparticle Drug Delivery Systems Company Evaluation Quadrant
3.4 Nanoparticle Drug Delivery Systems Market: Overall Company Footprint Analysis
3.4.1 Nanoparticle Drug Delivery Systems Market: Region Footprint
3.4.2 Nanoparticle Drug Delivery Systems Market: Company Product Type Footprint
3.4.3 Nanoparticle Drug Delivery Systems Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Nanoparticle Drug Delivery Systems Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nanoparticle Drug Delivery Systems Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Nanoparticle Drug Delivery Systems Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Nanoparticle Drug Delivery Systems Consumption Value Comparison
4.2.1 United States VS China: Nanoparticle Drug Delivery Systems Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Nanoparticle Drug Delivery Systems Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Nanoparticle Drug Delivery Systems Companies and Market Share, 2019-2024
4.3.1 United States Based Nanoparticle Drug Delivery Systems Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nanoparticle Drug Delivery Systems Revenue, (2019-2024)
4.4 China Based Companies Nanoparticle Drug Delivery Systems Revenue and Market Share, 2019-2024
4.4.1 China Based Nanoparticle Drug Delivery Systems Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nanoparticle Drug Delivery Systems Revenue, (2019-2024)
4.5 Rest of World Based Nanoparticle Drug Delivery Systems Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Nanoparticle Drug Delivery Systems Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nanoparticle Drug Delivery Systems Revenue (2019-2024)
5 Market Analysis by Type
5.1 World Nanoparticle Drug Delivery Systems Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Liposomes Drugs
5.2.2 Lipid Nanoparticle Drugs
5.3 Market Segment by Type
5.3.1 World Nanoparticle Drug Delivery Systems Market Size by Type (2019-2024)
5.3.2 World Nanoparticle Drug Delivery Systems Market Size by Type (2025-2030)
5.3.3 World Nanoparticle Drug Delivery Systems Market Size Market Share by Type (2025-2030)
6 Market Analysis by Application
6.1 World Nanoparticle Drug Delivery Systems Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Nanoparticle Drug Delivery Systems Market Size by Application (2019-2024)
6.3.2 World Nanoparticle Drug Delivery Systems Market Size by Application (2025-2030)
6.3.3 World Nanoparticle Drug Delivery Systems Market Size Market Share by Application (2019-2030)
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson Nanoparticle Drug Delivery Systems Product and Services
7.1.4 Johnson & Johnson Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Details
7.2.2 Sun Pharmaceutical Major Business
7.2.3 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Product and Services
7.2.4 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Sun Pharmaceutical Recent Developments/Updates
7.2.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.3 CSPC
7.3.1 CSPC Details
7.3.2 CSPC Major Business
7.3.3 CSPC Nanoparticle Drug Delivery Systems Product and Services
7.3.4 CSPC Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 CSPC Recent Developments/Updates
7.3.6 CSPC Competitive Strengths & Weaknesses
7.4 Kinyond
7.4.1 Kinyond Details
7.4.2 Kinyond Major Business
7.4.3 Kinyond Nanoparticle Drug Delivery Systems Product and Services
7.4.4 Kinyond Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Kinyond Recent Developments/Updates
7.4.6 Kinyond Competitive Strengths & Weaknesses
7.5 Teva
7.5.1 Teva Details
7.5.2 Teva Major Business
7.5.3 Teva Nanoparticle Drug Delivery Systems Product and Services
7.5.4 Teva Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Teva Recent Developments/Updates
7.5.6 Teva Competitive Strengths & Weaknesses
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Details
7.6.2 Fudan-Zhangjiang Major Business
7.6.3 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Product and Services
7.6.4 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Fudan-Zhangjiang Recent Developments/Updates
7.6.6 Fudan-Zhangjiang Competitive Strengths & Weaknesses
7.7 Zydus Cadila
7.7.1 Zydus Cadila Details
7.7.2 Zydus Cadila Major Business
7.7.3 Zydus Cadila Nanoparticle Drug Delivery Systems Product and Services
7.7.4 Zydus Cadila Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Zydus Cadila Recent Developments/Updates
7.7.6 Zydus Cadila Competitive Strengths & Weaknesses
7.8 TTY Biopharma
7.8.1 TTY Biopharma Details
7.8.2 TTY Biopharma Major Business
7.8.3 TTY Biopharma Nanoparticle Drug Delivery Systems Product and Services
7.8.4 TTY Biopharma Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 TTY Biopharma Recent Developments/Updates
7.8.6 TTY Biopharma Competitive Strengths & Weaknesses
7.9 Pacira
7.9.1 Pacira Details
7.9.2 Pacira Major Business
7.9.3 Pacira Nanoparticle Drug Delivery Systems Product and Services
7.9.4 Pacira Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Pacira Recent Developments/Updates
7.9.6 Pacira Competitive Strengths & Weaknesses
7.10 Luye Pharma
7.10.1 Luye Pharma Details
7.10.2 Luye Pharma Major Business
7.10.3 Luye Pharma Nanoparticle Drug Delivery Systems Product and Services
7.10.4 Luye Pharma Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Luye Pharma Recent Developments/Updates
7.10.6 Luye Pharma Competitive Strengths & Weaknesses
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Details
7.11.2 Leadiant Biosciences Major Business
7.11.3 Leadiant Biosciences Nanoparticle Drug Delivery Systems Product and Services
7.11.4 Leadiant Biosciences Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Leadiant Biosciences Recent Developments/Updates
7.11.6 Leadiant Biosciences Competitive Strengths & Weaknesses
7.12 Ipsen
7.12.1 Ipsen Details
7.12.2 Ipsen Major Business
7.12.3 Ipsen Nanoparticle Drug Delivery Systems Product and Services
7.12.4 Ipsen Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Ipsen Recent Developments/Updates
7.12.6 Ipsen Competitive Strengths & Weaknesses
7.13 Sayre Therapeutics
7.13.1 Sayre Therapeutics Details
7.13.2 Sayre Therapeutics Major Business
7.13.3 Sayre Therapeutics Nanoparticle Drug Delivery Systems Product and Services
7.13.4 Sayre Therapeutics Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Sayre Therapeutics Recent Developments/Updates
7.13.6 Sayre Therapeutics Competitive Strengths & Weaknesses
7.14 Jazz
7.14.1 Jazz Details
7.14.2 Jazz Major Business
7.14.3 Jazz Nanoparticle Drug Delivery Systems Product and Services
7.14.4 Jazz Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Jazz Recent Developments/Updates
7.14.6 Jazz Competitive Strengths & Weaknesses
7.15 Alnylam
7.15.1 Alnylam Details
7.15.2 Alnylam Major Business
7.15.3 Alnylam Nanoparticle Drug Delivery Systems Product and Services
7.15.4 Alnylam Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Alnylam Recent Developments/Updates
7.15.6 Alnylam Competitive Strengths & Weaknesses
7.16 Bausch Health
7.16.1 Bausch Health Details
7.16.2 Bausch Health Major Business
7.16.3 Bausch Health Nanoparticle Drug Delivery Systems Product and Services
7.16.4 Bausch Health Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Bausch Health Recent Developments/Updates
7.16.6 Bausch Health Competitive Strengths & Weaknesses
7.17 Acrotech Biopharma
7.17.1 Acrotech Biopharma Details
7.17.2 Acrotech Biopharma Major Business
7.17.3 Acrotech Biopharma Nanoparticle Drug Delivery Systems Product and Services
7.17.4 Acrotech Biopharma Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Acrotech Biopharma Recent Developments/Updates
7.17.6 Acrotech Biopharma Competitive Strengths & Weaknesses
7.18 Takeda
7.18.1 Takeda Details
7.18.2 Takeda Major Business
7.18.3 Takeda Nanoparticle Drug Delivery Systems Product and Services
7.18.4 Takeda Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Takeda Recent Developments/Updates
7.18.6 Takeda Competitive Strengths & Weaknesses
7.19 Chiesi Farmaceutici
7.19.1 Chiesi Farmaceutici Details
7.19.2 Chiesi Farmaceutici Major Business
7.19.3 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Product and Services
7.19.4 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Chiesi Farmaceutici Recent Developments/Updates
7.19.6 Chiesi Farmaceutici Competitive Strengths & Weaknesses
7.20 Gilead Sciences
7.20.1 Gilead Sciences Details
7.20.2 Gilead Sciences Major Business
7.20.3 Gilead Sciences Nanoparticle Drug Delivery Systems Product and Services
7.20.4 Gilead Sciences Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Gilead Sciences Recent Developments/Updates
7.20.6 Gilead Sciences Competitive Strengths & Weaknesses
7.21 Pfizer
7.21.1 Pfizer Details
7.21.2 Pfizer Major Business
7.21.3 Pfizer Nanoparticle Drug Delivery Systems Product and Services
7.21.4 Pfizer Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 Pfizer Recent Developments/Updates
7.21.6 Pfizer Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Nanoparticle Drug Delivery Systems Industry Chain
8.2 Nanoparticle Drug Delivery Systems Upstream Analysis
8.3 Nanoparticle Drug Delivery Systems Midstream Analysis
8.4 Nanoparticle Drug Delivery Systems Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.